RI
RPRX

RTW Investments’s Repros Therapeutics Inc. RPRX Stock Holding History

RTW Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-232,830
Closed -$1.73M – 47
2015
Q3 		$1.73M Buy
232,830
+3,466
+2% +$26.5K 0.54% 27
2015
Q2 		$1.64M Hold
229,364
– – 0.48% 27
2015
Q1 		$1.97M Hold
229,364
– – 0.89% 15
2014
Q4 		$2.29M Buy
+229,364
New +$1.96M 0.85% 15

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

RTW Investments's RPRX Position: Q4 2015 in Review

RTW Investments sold out of Repros Therapeutics Inc. (RPRX) in Q4 2015, closing a stake of 232,830 shares — an estimated $1.73M sold.

RTW Investments first reported a position in RPRX in Q4 2014 and held it in 4 quarters. The position peaked at $2.29M in Q4 2014. 56 funds tracked by Wall St. Rank hold RPRX as of Q4 2015.

  • RTW Investments reported no remaining Repros Therapeutics Inc. position as of Q4 2015 after selling out during the quarter.
  • RTW Investments sold 232,830 Repros Therapeutics Inc. shares in Q4 2015, an estimated $1.73M.
  • RTW Investments first reported a position in Repros Therapeutics Inc. in Q4 2014 and held it in 4 quarters.
  • RTW Investments's Repros Therapeutics Inc. position peaked at $2.29M in Q4 2014.
  • 56 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2015.

Based on RTW Investments's 13F filing for Q4 2015, filed 16 Feb 2016.